Superficial Cervical Plexus Block With Either Clavipectoral Fascial Plane Block or Interscalene Brachial Block for Clavicle Surgeries Anesthesia

NCT ID: NCT06831604

Last Updated: 2025-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-20

Study Completion Date

2026-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate and compare the efficacy and safety of ultrasound guided superficial cervical plexus block (SCPB) with either clavipectoral fascial plane block (CPB) or interscalene brachial plexus block (ISBP) as an anesthetic technique for clavicle surgeries.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Clavicular fracture is the most common injury in the shoulder, it occurs in 35% of shoulder girdle fractures. Clavicle surgeries often involve addressing fractures, dislocations, or corrective procedures, and they generally require precise and effective pain control.

Traditional superficial cervical plexus block (SCPB) combined with interscalene brachial plexus block (ISBP) can be used in the operation of clavicle fracture.

The SCPB targets the cervical plexus, providing sensory anesthesia to the skin overlying the cervical and upper thoracic regions. It is often used in conjunction with other blocks to enhance analgesia in the upper shoulder and clavicle area.

The ISBP block involves the administration of local anesthetic at the level of the brachial plexus, typically performed between the anterior and middle scalene muscles. This approach provides comprehensive analgesia for the shoulder, upper arm, and part of the clavicular area.

Clavipectoral fascial plane block (CPB) is a new regional nerve block and can be used in anesthesia and postoperative analgesia for clavicle fracture surgery. CPB provides analgesia to the clavicular region and the upper shoulder.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ultrasound Superficial Cervical Plexus Block Clavipectoral Fascial Plane Block Interscalene Brachial Block Clavicle Surgeries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I

Patients will receive Superficial Cervical Plexus Block (SCPB) and Clavipectoral Fascial Plane Block (CPB).

Group Type EXPERIMENTAL

Superficial Cervical Plexus Block (SCPB) and Clavipectoral Fascial Plane Block (CPB)

Intervention Type DRUG

Patients will receive Superficial Cervical Plexus Block (SCPB) and Clavipectoral Fascial Plane Block (CPB).

Group II

Patients will receive Superficial Cervical Plexus Block (SCPB) and Interscalene Brachial Block (ISBP).

Group Type EXPERIMENTAL

Superficial Cervical Plexus Block (SCPB) and Interscalene Brachial Block (ISBP)

Intervention Type DRUG

Patients will receive Superficial Cervical Plexus Block (SCPB) and Interscalene Brachial Block (ISBP)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Superficial Cervical Plexus Block (SCPB) and Clavipectoral Fascial Plane Block (CPB)

Patients will receive Superficial Cervical Plexus Block (SCPB) and Clavipectoral Fascial Plane Block (CPB).

Intervention Type DRUG

Superficial Cervical Plexus Block (SCPB) and Interscalene Brachial Block (ISBP)

Patients will receive Superficial Cervical Plexus Block (SCPB) and Interscalene Brachial Block (ISBP)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Group I Group II

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 to 65 years.
* Both sexes.
* American Society of Anesthesiologists (ASA) physical status I, II.
* Patients with unilateral clavicular fractures undergo elective internal fixation of clavicle fractures.

Exclusion Criteria

* Coagulopathy.
* Patients with infection at block site.
* Allergy to local anesthetics.
* Patient with morbid obesity (body mass index \>35 kg/m2).
* Pre-existing neurological disease.
* Difficult communication.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tanta University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Mohamed Aboeldahab

Assistant Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tanta University

Tanta, El-Gharbia, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed M Aboeldahab, Master

Role: CONTACT

00201069784512

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed M Aboeldahab, Master

Role: primary

00201069784512

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

36265MD331/12/24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.